About the Macula Society
Founded in 1977, the Macula Society is a forum for new research in retinal vascular and macular diseases. Membership is by application, with acceptance criteria including extensive contribution to retinal literature. The Macula Society recognizes outstanding achievement by its members and others through awards and lectures, and holds an annual meeting open to members, their guests, co-authors, and supporting company representatives.
Our email address has changed! Please use
for all future communications!
Julia A. Haller, MD
Immediate Past President
Mark W. Johnson, MD
Macula Society Endowment Fund
The Macula Society Educational Endowment provides a revenue stream to fund various educational initiatives in perpetuity, independent of year-to-year fluctuations in corporate support and other society income sources.
The DRCR Retina Network is planning an exciting new Phase III clinical trial to prevent visual acuity loss due to radiation retinopathy (RR). Eligible participants will be randomized to receive either repeated injections of anti-VEGF, long-active steroid, or observation following treatment of choroidal melanoma with I-125 plaque brachytherapy.
Any interested physicians or clinical sites should contact email@example.com to learn more about joining the Network.